We are live on ! Find out more
IVVD icon

Invivyd
IVVD

86 hedge funds and large institutions have $321M invested in Invivyd in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,754% more call options, than puts

Call options by funds: $4.01M | Put options by funds: $104K

540% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 5

46% more capital invested

Capital invested by funds: $220M → $321M (+$101M)

46% more funds holding

Funds holding: 59 → 86 (+27)

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

15.05% more ownership

Funds ownership: 50.67% → 65.72% (+15%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
86
Holders Change
+27
Holders Change %
+45.76%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
25
Reduced
18
Closed
5
Calls
$4.01M
Puts
$104K
Net Calls
+$3.9M
Net Calls Change
+$3.46M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$45.3M
2
MC
Maverick Capital
Texas
+$10M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$5.16M
4
Millennium Management
Millennium Management
New York
+$4.41M
5
Marshall Wace
Marshall Wace
United Kingdom
+$3M

Top Sellers

1
O
OrbiMed
New York
-$5.94M
2
AI
Alphabet Inc
California
-$4.77M
3
BCM
Bridgeway Capital Management
Texas
-$767K
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$569K
5
AI
Acuitas Investments
Washington
-$543K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Maverick Capital
Texas
$52.2M +$10M +2,421,838 +26%
DTC
2
Deep Track Capital
Connecticut
$48.6M +$45.3M +10,953,937 New
MCM
3
M28 Capital Management
Connecticut
$41.1M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$37.3M -$21.9K -5,305 -0.1%
AI
5
Alphabet Inc
California
$20.1M -$4.77M -1,153,663 -20%
SPC
6
Slate Path Capital
New York
$16.6M – – –
6CM
7
683 Capital Management
New York
$15.4M -$516K -125,000 -3%
O
8
OrbiMed
New York
$11.9M -$5.94M -1,437,265 -35%
Vanguard Group
9
Vanguard Group
Pennsylvania
$11.6M +$403K +97,496 +4%
BCLSI
10
Bain Capital Life Sciences Investors
Massachusetts
$7.99M -$569K -137,612 -7%
Millennium Management
11
Millennium Management
New York
$6.76M +$4.41M +1,067,394 +234%
RG
12
Redmile Group
California
$6.4M – – –
GGHC
13
Gilder Gagnon Howe & Co
New York
$5.55M +$5.16M +1,249,111 New
BlackRock
14
BlackRock
New York
$3.89M -$96.7K -23,411 -3%
Marshall Wace
15
Marshall Wace
United Kingdom
$3.35M +$3M +725,496 +2,467%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.72M +$125K +30,369 +5%
Goldman Sachs
17
Goldman Sachs
New York
$2.68M +$2.27M +548,770 +1,014%
Deutsche Bank
18
Deutsche Bank
Germany
$2.6M +$2.42M +585,385 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$2.52M +$216K +52,341 +10%
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
$1.93M +$321K +77,603 +22%
Jane Street
21
Jane Street
New York
$1.45M +$547K +132,507 +68%
BCM
22
Bridgeway Capital Management
Texas
$1.44M -$767K -185,600 -36%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$1.39M +$788K +190,623 +156%
Charles Schwab
24
Charles Schwab
California
$1.38M +$30.3K +7,339 +2%
Squarepoint
25
Squarepoint
New York
$1.26M +$752K +182,071 +178%
1
2 3 4

IVVD Hedge Fund Activity: Q1 2024 in Review

86 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q1 2024, worth a combined $321M — up 46% from $220M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new IVVD positions and 5 closed out — a net gain of 27 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $45.3M. The largest seller was OrbiMed, cutting an estimated $5.94M.

  • 86 institutional investors held Invivyd (IVVD) as of Q1 2024, up from 59 in Q4 2023.
  • Funds reported $321M of Invivyd stock for Q1 2024, up 46% quarter-over-quarter.
  • 32 funds opened new Invivyd positions in Q1 2024 and 5 closed out, a net change of +27 holders.
  • The largest Invivyd buyer in Q1 2024 was Deep Track Capital, an estimated $45.3M added.
  • The largest Invivyd seller in Q1 2024 was OrbiMed, an estimated $5.94M sold.

Based on aggregated 13F filings for Q1 2024.